The Science of Oral Peptide Delivery

Oral delivery is attractive because it is familiar and convenient. For peptides, it is also one of the most technically demanding routes.

The gastrointestinal tract is designed to digest peptides

Acidic conditions and digestive enzymes break dietary proteins and peptides into smaller fragments and amino acids. A therapeutic or research peptide entering this environment may be hydrolyzed before it reaches an absorptive surface. Enteric coatings and protease inhibitors can reduce exposure to some of these conditions, but each strategy has limitations.

Mucus and epithelium restrict transport

After surviving digestion, a peptide must diffuse through mucus and cross the intestinal epithelium. Tight junctions limit paracellular transport, while the lipid membrane limits transcellular passage of polar macromolecules. Efflux, intracellular degradation, and first-pass processing can further reduce systemic exposure.

Absorption enhancers can increase permeability

Some oral peptide platforms use permeation enhancers that temporarily alter membrane or tight-junction behavior. The challenge is achieving meaningful absorption without causing unacceptable irritation or allowing unintended luminal substances to cross the barrier.

Carriers and devices are being explored

Nanoparticles, liposomes, polymeric systems, microneedle capsules, enzyme-responsive materials, and targeted carriers are among the strategies under investigation. These technologies must protect the peptide, release it at the correct location, and produce consistent exposure across variable gastrointestinal conditions.

Bioavailability is not the only metric

Low absolute bioavailability may still be useful for highly potent peptides if exposure is predictable. Variability can be more problematic than a low mean value. Food effects, gastric emptying, pH, motility, and individual physiology can produce substantial differences.

A capsule is a format, not evidence

The existence of a capsule or tablet presentation does not establish that the peptide is absorbed, stable, or biologically active after oral administration. Those questions require product-specific pharmacokinetic and pharmacodynamic studies.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.